metabolomics

In this episode, Jonathan is joined by Brian Van Tine, Professor of Medicine in medical oncology and Professor of Paediatrics at the Washington University School of Medicine (WUSM) in St. Louis, Missouri, USA, to provide an overview of his clinical interest in soft tissue and bone sarcomas. The pair explore immunotherapy, specifically monoclonal antibodies and immune checkpoint blockade, and further dive into metabolomics and its relevance to oncology.  

Use the following timestamps to navigate the content in this episode: 

This week my guest is Dr. Paniz Jasbi, CEO of Theriome, a trailblazing company at the forefront of metabolomics research. In this conversation, we delve deep into the world of metabolomics, uncovering the fascinating science behind how metabolism impacts every facet of our health, far beyond the narrow lens of weight loss.

Join us as Dr. Jasbi takes us on a journey through the groundbreaking work of Theriome, shedding light on how their pioneering research is revolutionizing our understanding of human health. From decoding the intricacies of metabolic pathways to exploring the potential applications in precision medicine, this episode promises to expand your horizons on the pivotal role metabolism plays in our well-being.

If you're curious about the cutting-edge science that's reshaping the future of healthcare and the profound implications it holds for your own health journey, don't miss this insightful conversation with Dr. Paniz Jasbi. It's time to rethink what metabolism truly means for our overall health.

Connect with Dr. Jasbi

https://therio.me/pages/about-us 

info@therio.me 

Instagram @theriometest

Facebook @Theriome

LinkedIn @theriome

Connect with Liz

Instagram @motherhoodunstressed

hello@motherhoodunstressed.com

Web: https://www.motherhoodunstressed.com 

Dear listeners,

This is a bittersweet moment for us. With this episode, we conclude the Personalized Medicine Podcast series. 

We would like to thank all of you for staying with us over the last 3 years! This has been an amazing ride and we appreciate your constant support and feedback. We hope you enjoyed listening to this show as much as we enjoyed making it for you.

In this final episode, our team sits down once more to remember how it all started and how the team came together over these years. We share our most memorable podcast moments and words of gratitude to our guests and listeners. 

Thank you so much for being with us on this journey! 

Stay tuned for our next projects.

Sincerely yours,

Oleksandr (aka Sasha), Luisa, Aradhana, Ivana, Ting and Mehar

Recorded at the University of Calgary's Alberta Centre for Advanced Diagnostics (ACAD), we chat with Dr. Stephanie Bishop, PhD, & Dr. Mehdi Mohammadi, PhD, post doctoral associates in the Department of Biological Sciences, Faculty of Science. They share their innovation journey of how their research and expertise in metabolomics led to the creation of their company, Fluidome.

Learn how to move your research-to-impact in the Innovation@UCalgary ecosystem.

Learn more about Fluidome.

Learn more about ACAD. 

 Dr. Tommy Sors, Assistant Director of the Purdue Institute of Inflammation, Immunology and Infectious Disease (PI4D), explains the role that STEM professionals in all fields play in sequencing genes to understand the instructions for life found in every cell. This field of study is known as genomics, but within this field, there are many other “-omics.” How about the field of study involving RNA copied from DNA made within the cell? Transcriptomics. The field of instructions on how to make proteins? Proteomics. The study of proteins metabolizing within the cell? Metabolomics. Each of these fields creates a flood of information that requires computational science to help scientists better understand the data.

David Brady, ND, DC, CCN, DACBN, IFMCP, FACN, MS, DC, joins Integrative Practitioner associate editor, Avery St. Onge, to discuss the benefits of using omics (i.e., microbiomics, genomics, metabolomics, etc.) testing in a clinical practice to help personalize the treatment of patients with mental health issues. This episode is sponsored by Diagnostic Solutions Laboratory.

Find us at integrativepractitioner.com or e-mail us at IPEditor@divcom.com.

Theme music: “Upbeat Party” by Scott Holmes via freemusicarchive.org and “Carefree” by Kevin Mcleod via incompetech.com.

Michael Snyder

Dr. Michael Snyder is the director for the Center for Genomics and Personalized Medicine at Stanford and a pioneer and advocate of "deep profiling." Deep profiling seeks to apply intelligent analysis to large data sets to yield specialized clinical insight, ranging from common consumer-grade wearables like Apple Watches to whole-body MRI, continuous glucose monitoring, and metabolomics.

In this episode, we discuss:

• (00:00) Introduction to Dr. Michael Snyder
• (12:51) Continuous glucose monitor use in people without diabetes
• (31:04) A smartwatch helped diagnose Dr. Snyder's Lyme disease
• (34:00) Predicting other illnesses with smartwatches
• (40:41) Detecting airborne pollutants in the exosome 
• (51:04) Genetics and metabolism tell us our Ageotypes
• (58:05) Exercise is most important for longevity
• (01:03:11) Dr. Snyder's lifestyle habits

If you’re interested in learning more, you can read the full show notes.

Join over 300,000 people and get the latest distilled information on personalized medicine straight to your inbox weekly: https://www.foundmyfitness.com/newsletter

Become a FoundMyFitness premium member to get access to exclusive episodes, emails, live Q+A’s with Rhonda and more: https://www.foundmyfitness.com/crowdsponsor

The question of “What is Metabolomics” has been buzzing around the scientific community. With the advances of new technology, a gateway to studying metabolomics has been opened. Over recent years, microbiome researchers have begun to incorporate  metabolomics, the “missing piece of the puzzle”, as part of their multiomics studies  To understand that missing piece more clearly and what it could mean for the future of multiomics, we feature two experts from DNA Genotek,  Dr. Heloise Breton, Product Manager for Microbiome products, and Dr. Olle de Bruin, R&D Scientist - microbiome/metabolomics.

Host: Vincent Racaniello

Guest: Ileana Cristea

Vincent meets up with Ileana at Princeton University to talk about how her laboratory integrates molecular virology, mass spectrometry-based proteomics, and bioinformatics to unravel the interplay between virus and host.

Links for this episode

• Cristea Laboratory
• Ileana's work previously on TWiV 269
• Blowing off steam (Cell Host Micr)
• Nuclear viral DNA sensors (J Biol Chem)
• mSystems
• Video of this episode - view at YouTube (coming soon!)

Send your virology questions and comments to twiv@twiv.tv

In episode 45 of MicrobeWorld Video, filmed at the American Association for the Advancement of Science Meeting in Washington, D.C., Dr. Stan Maloy talks with Jeremy Nicholson, Head of the Department of Surgery & Cancer at Imperial College London, about his work with metabolomics and the human gut.

Maloy and Nicholson discuss the science of metabolomics, the systematic study of the unique chemical fingerprints that specific cellular processes leave behind, and how gut microbial metabolites are part of the diagnostic pattern of results when looking at a host of diseases. Nicholson, who is  known for his work in pharmaco-metabonomics, also discusses the potential for personalized medicine.

In episode 45 of MicrobeWorld Video, filmed at the American Association for the Advancement of Science Meeting in Washington, D.C., Dr. Stan Maloy talks with Jeremy Nicholson, Head of the Department of Surgery & Cancer at Imperial College London, about his work with metabolomics and the human gut.

Maloy and Nicholson discuss the science of metabolomics, the systematic study of the unique chemical fingerprints that specific cellular processes leave behind, and how gut microbial metabolites are part of the diagnostic pattern of results when looking at a host of diseases. Nicholson, who is  known for his work in pharmaco-metabonomics, also discusses the potential for personalized medicine.

In episode 45 of MicrobeWorld Video, filmed at the American Association for the Advancement of Science Meeting in Washington, D.C., Dr. Stan Maloy talks with Jeremy Nicholson, Head of the Department of Surgery & Cancer at Imperial College London, about his work with metabolomics and the human gut.

Maloy and Nicholson discuss the science of metabolomics, the systematic study of the unique chemical fingerprints that specific cellular processes leave behind, and how gut microbial metabolites are part of the diagnostic pattern of results when looking at a host of diseases. Nicholson, who is  known for his work in pharmaco-metabonomics, also discusses the potential for personalized medicine.